Showing results (51-60 of 144) with videos related to

Sort By:
Pageof 15
Journal of Lower Genital Tract Disease|March 26, 2016
Comparison of Colposcopic Impression Based on Live Colposcopy and Evaluation of Static Digital ImagesAngela H Liu, Michael A Gold, Mark Schiffman, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|May 21, 2005
Towards improved biomarker studies of cervical neoplasia: effects of precolposcopic procedures on gene expression patternsSophia S Wang, Abhijit Dasgupta, Mark E Sherman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2012
Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 StudyJoan L Walker, Marion R Piedmonte, Nick M Spirtos, et al.
Gynecologic Oncology|November 16, 2010
Low-dose abdominal radiation as a docetaxel chemosensitizer for recurrent epithelial ovarian cancer: a phase I study of the Gynecologic Oncology GroupCharles A Kunos, Michael W Sill, Thomas E Buekers, et al.
Gynecologic Oncology|December 21, 2010
A phase II study of two topotecan regimens evaluated in recurrent platinum-sensitive ovarian, fallopian tube or primary peritoneal cancer: a Gynecologic Oncology Group Study (GOG 146Q)Thomas J Herzog, Michael W Sill, Joan L Walker, et al.
Gynecologic Oncology|May 11, 2015
A phase I study of IV doxorubicin plus intraperitoneal (IP) paclitaxel and IV or IP cisplatin in endometrial cancer patients at high risk for peritoneal failure (GOG 9920): an NRG Oncology/Gynecologic Oncology Group studyD Scott McMeekin, Michael W Sill, Joan L Walker, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|October 2, 2014
Histologic effects of medroxyprogesterone acetate on endometrioid endometrial adenocarcinoma: a Gynecologic Oncology Group studyRichard J Zaino, William E Brady, William Todd, et al.
Cancer|May 16, 2007
Lymphadenectomy in endometrioid uterine cancer staging: how many lymph nodes are enough? A study of 11,443 patientsJohn K Chan, Renata Urban, Michael K Cheung, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 24, 2015
Expression Patterns of the Wnt Pathway Inhibitors Dickkopf3 and Secreted Frizzled-Related Proteins 1 and 4 in Endometrial Endometrioid Adenocarcinoma: An NRG Oncology/Gynecologic Oncology Group StudyRamez N Eskander, Shamshad Ali, Thanh Dellinger, et al.
Gynecologic Oncology|August 1, 2017
Randomized phase IIB evaluation of weekly paclitaxel versus weekly paclitaxel with oncolytic reovirus (Reolysin®) in recurrent ovarian, tubal, or peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group studyDavid E Cohn, Michael W Sill, Joan L Walker, et al.
Pageof 15